ReviewCancers2025
Comparing Isocitrate Dehydrogenase Inhibitors with Procarbazine, Lomustine, and Vincristine Chemotherapy for Oligodendrogliomas.
Gerardo Duran, Diego Pichardo-Rojas, Ahmed Hashim Ali, Peter Passias, Angela Downes, Wilson Z Ray, Gregory J Zipfel, Hakeem J Shakir, Andrew Bauer, Andrew Jea and 4 more
Abstract readReview
In one paragraphReview in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Gerardo DuranDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.ORCID 0009-0008-7658-829X Ahmed Hashim AliDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.ORCID 0009-0002-1535-4680 Angela DownesDepartment of Neurosurgery and Orthopedic Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
Wilson Z RayDepartment of Neurosurgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Gregory J ZipfelDepartment of Neurosurgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Hakeem J ShakirDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.ORCID 0000-0003-4234-340X Andrew BauerDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.ORCID 0000-0001-9458-6951 Andrew JeaDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
Ian F DunnDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
Jeffrey A ZuccatoDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.ORCID 0000-0001-5418-8238 Christopher S GraffeoDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
M Burhan JanjuaDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The abstract has been submitted for presentation to the AANS 2026 meeting being held in San Antonio, TX, USA.
Indexed as
isocitrate dehydrogenase inhibitoroligodendrogliomaprocarbazine lomustine vincristine chemotherapytargeted therapy
Identifiers
PMID41375081
PMCPMC12691507
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390